ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

GAO Study Finds Lumpectomy Effective As Mastectomy In Trials And In Practice

November 25, 1994

Oxandrolone And Education Improves Weight Gain

February 28, 2003

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003